Shandong Buchang Pharmaceuticals Co., Ltd.

Shanghai Stock Exchange 603858.SS

Shandong Buchang Pharmaceuticals Co., Ltd. Market Capitalization on January 14, 2025: USD 2.31 B

Shandong Buchang Pharmaceuticals Co., Ltd. Market Capitalization is USD 2.31 B on January 14, 2025, a -11.13% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
  • Shandong Buchang Pharmaceuticals Co., Ltd. 52-week high Market Capitalization is USD 2.95 B on October 08, 2024, which is 27.80% above the current Market Capitalization.
  • Shandong Buchang Pharmaceuticals Co., Ltd. 52-week low Market Capitalization is USD 2.27 B on September 10, 2024, which is -1.85% below the current Market Capitalization.
  • Shandong Buchang Pharmaceuticals Co., Ltd. average Market Capitalization for the last 52 weeks is USD 2.54 B.
Key data
Date Market Capitalization Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S)
Market news
Loading...
Shanghai Stock Exchange: 603858.SS

Shandong Buchang Pharmaceuticals Co., Ltd.

CEO Mr. Chao Zhao
IPO Date Nov. 18, 2016
Location China
Headquarters No. 369 Zhonghua West Road
Employees 8,311
Sector Health Care
Industries
Description

Shandong Buchang Pharmaceuticals Co., Ltd. engages in the research and development, production, and sale of medicines in China. It offers medicines to treat cardiac and cerebral vascular, urinary and digestive, respiratory, gynecological, and other diseases, as well as diabetes. The company was founded in 1993 and is based in Heze, China. Shandong Buchang Pharmaceuticals Co., Ltd. was a former subsidiary of Shanghai Zhangjiang (Group) Co., Ltd.

Similar companies

600566.SS

Hubei Jumpcan Pharmaceutical Co., Ltd.

USD 3.86

1.95%

600998.SS

Jointown Pharmaceutical Group Co., Ltd

USD 0.67

1.67%

601225.SS

Shaanxi Coal Industry Company Limited

USD 3.02

0.28%

StockViz Staff

January 15, 2025

Any question? Send us an email